Search Results - "Uppal, Shelley"

The clinical utility of teledermoscopy in the era of telemedicine by Uppal, Shelley K., Beer, Jacob, Hadeler, Edward, Gitlow, Howard, Nouri, Keyvan

“…Teledermoscopy is a novel diagnostic tool for the prevention, diagnosis, and treatment of skin disease when direct visualization of lesions is difficult. It is…”
Get full text

Review and analysis of biologic therapies currently in phase II and phase III clinical trials for atopic dermatitis by Uppal, Shelley K., Kearns, Donovan G., Chat, Vipawee S., Han, George, Wu, Jashin J.

“…Biologic medications are recent advances that have clinical significance in the treatment of moderate-to-severe AD. A systemic literature review was performed…”
Get full text

Abrocitinib for atopic dermatitis by Uppal, Shelley K, Chat, Vipawee S, Kearns, Donovan G, Wu, Jashin J

Get full text

Clinical management of psoriasis patients during the COVID-19 pandemic by Chat, Vipawee S., Uppal, Shelley K., Kearns, Donovan G., Wu, Jashin J.

“…Psoriasis is a systemic immune-mediated inflammatory disease that requires consistent treatment and follow-up. Given that COVID-19 will persist in the coming…”
Get full text

Ruxolitinib cream for the treatment of vitiligo by Uppal, Shelley K, Kearns, Donovan G, Chat, Vipawee S, Wu, Jashin J

Get full text

Comparison of guidelines for the use of Ustekinumab for psoriasis in the United States, Europe, and the United Kingdom: A critical appraisal and comprehensive review by Chat, Vipawee S., Uppal, Shelley K., Kearns, Donovan G., Wu, Jashin J.

“…The aim of this review is to compare and contrast evidence‐based clinical practice guidelines from global dermatological organizations for the use of…”
Get full text

Risk of atypical mycobacterial infections in psoriasis patients during IL-17 inhibitor therapy by Chat, Vipawee S., Kearns, Donovan G., Uppal, Shelley K., Wu, Jashin J.

Get full text

Management of Psoriasis With Topicals: Applying the 2020 AAD-NPF Guidelines of Care to Clinical Practice by Chat, Vipawee S, Kearns, Donovan G, Uppal, Shelley K, Han, George, Wu, Jashin J

Get full text

Translating the 2019 AAD-NPF Guidelines of Care for Psoriasis With Attention to Comorbidities by Chat, Vipawee S, Uppal, Shelley K, Kearns, Donovan G, Han, George, Wu, Jashin J

Get full text

Translating the 2020 AAD-NPF Guidelines of Care for the Management of Psoriasis With Systemic Nonbiologics to Clinical Practice by Chat, Vipawee S, Uppal, Shelley K, Kearns, Donovan G, Han, George, Wu, Jashin J

“…In 2020, the American Academy of Dermatology (AAD) and the National Psoriasis Foundation (NPF) released a set of guidelines for the management of psoriasis in…”
Get full text

Dermatologists as social media contributors during the COVID-19 pandemic by Uppal, Shelley K, Kearns, Donovan G, Chat, Vipawee S, Wu, Jashin J

Get full text

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic by Kearns, Donovan G., Uppal, Shelley, Chat, Vipawee S., Wu, Jashin J.

Get full text

Identifying Areas for Improvement in Remote Skin Cancer Management: Surveillance, Diagnostics, and Skin of Color by Hadeler, Edward, Beer, Jacob, Uppal, Shelley, Nouri, Keyvan

Get more information

Applying to dermatology residency during the COVID-19 pandemic by Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.

Get full text

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic by Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.

Get full text

Use of systemic therapies for psoriasis in the COVID-19 era by Kearns, Donovan G., Uppal, Shelley, Chat, Vipawee S., Wu, Jashin J.

“…In late 2019 a viral pneumonia began to spread across the world. The viral disease, COVID-19, is now officially a pandemic, causing concern for the potential…”
Get full text

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic” by Kearns, Donovan G., Chat, Vipawee S., Uppal, Shelley, Wu, Jashin J.

Get full text

Assessing the Risk of Apremilast Use for Psoriasis During the COVID-19 Pandemic by Kearns, Donovan G, Uppal, Shelley, Chat, Vipawee S, Wu, Jashin J

Get more information

Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review by Kearns, Donovan G., Uppal, Shelley, Chat, Vipawee S., Wu, Jashin J.

Get full text

Comparison of Guidelines for the Use of Interleukin-17 Inhibitors for Psoriasis in the United States, Britain, and Europe: A Critical Appraisal and Comprehensive Review by Kearns, Donovan G, Uppal, Shelley, Chat, Vipawee S, Wu, Jashin J

“…Interleukin (IL)-17 inhibitors are a newer class of biologic used to treat patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. We…”
Get full text